Your browser doesn't support javascript.
loading
A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors.
Mesrouze, Yannick; Aguilar, Gustavo; Bokhovchuk, Fedir; Martin, Typhaine; Delaunay, Clara; Villard, Frédéric; Meyerhofer, Marco; Zimmermann, Catherine; Fontana, Patrizia; Wille, Roman; Vorherr, Thomas; Erdmann, Dirk; Furet, Pascal; Scheufler, Clemens; Schmelzle, Tobias; Affolter, Markus; Chène, Patrick.
Afiliación
  • Mesrouze Y; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Aguilar G; Biozentrum, University of Basel, Klingelbergstrasse 50/70, 4056, Basel, Switzerland.
  • Bokhovchuk F; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Martin T; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Delaunay C; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Villard F; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Meyerhofer M; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Zimmermann C; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Fontana P; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Wille R; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Vorherr T; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Erdmann D; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Furet P; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Scheufler C; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Schmelzle T; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
  • Affolter M; Biozentrum, University of Basel, Klingelbergstrasse 50/70, 4056, Basel, Switzerland.
  • Chène P; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland. patrick_chene@yahoo.com.
Sci Rep ; 10(1): 17442, 2020 10 15.
Article en En | MEDLINE | ID: mdl-33060790
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas Nucleares / Proteínas de Unión al ADN / Proteínas Musculares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas Nucleares / Proteínas de Unión al ADN / Proteínas Musculares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido